[go: up one dir, main page]

HK40080165A - Therapy for the treatment of cancer - Google Patents

Therapy for the treatment of cancer Download PDF

Info

Publication number
HK40080165A
HK40080165A HK62023069501.2A HK62023069501A HK40080165A HK 40080165 A HK40080165 A HK 40080165A HK 62023069501 A HK62023069501 A HK 62023069501A HK 40080165 A HK40080165 A HK 40080165A
Authority
HK
Hong Kong
Prior art keywords
cancer
therapy
treatment
Prior art date
Application number
HK62023069501.2A
Other languages
Chinese (zh)
Inventor
Chad Bjorklund
Hsiling CHIU
Patrick HAGNER
Jian KANG
Anjan THAKURTA
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of HK40080165A publication Critical patent/HK40080165A/en

Links

HK62023069501.2A 2019-12-02 2020-12-01 Therapy for the treatment of cancer HK40080165A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/942,378 2019-12-02

Publications (1)

Publication Number Publication Date
HK40080165A true HK40080165A (en) 2023-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP3849549A4 (en) Combination therapy for the treatment of triple-negative breast cancer
EP3781564A4 (en) Compounds for the treatment of cancer
ZA202206743B (en) Therapy for the treatment of cancer
EP4010081A4 (en) Combination therapy for treatment of cancer
EP3860610A4 (en) Combination therapy for the treatment of cancer
EP3897649A4 (en) Combination therapy of solid cancer
IL323370A (en) Indazolyl-isoxasole derivative for the treatment of cancer
IL284162A (en) Combination therapy for the treatment of cancer
EP3962524A4 (en) Cancer treatment
EP3856784A4 (en) Pharmaceutical combination for the treatment of cancer
HK40082904A (en) Therapy for the treatment of cancer
HK40080165A (en) Therapy for the treatment of cancer
HK40061708A (en) Combination therapy for the treatment of cancer
HK40060019A (en) Combination therapy for the treatment of cancer
HK40097873A (en) Combination therapy for the treatment of cancer
HK40097938A (en) Combination therapy for the treatment of cancer
HK40122434A (en) Pharmaceutical combination for the treatment of cancer
HK40114414A (en) Dr5-targeting multabodies for the treatment of cancer
HK40101281A (en) Combination therapies for the treatment of cancer
HK40094743A (en) Combinations for the treatment of cancer
HK40112300A (en) Methods for the treatment of cancer
HK40103377A (en) Combination therapies for the treatment of cancer
HK40103172A (en) Combination therapies for the treatment of cancer
HK40103380A (en) Combination therapies for the treatment of cancer
HK40080960A (en) Combination therapy for treating cancer